Whole-Body MR Imaging for Staging Malignant Lymphomas
N/A
8 Years
N/A
8 Years
N/A
Not Enrolling
Both
Malignant Lymphoma, Hodgkin's Disease, Non-Hodgkin's Lymphoma
Both
Malignant Lymphoma, Hodgkin's Disease, Non-Hodgkin's Lymphoma
Trial Information
Whole-Body MR Imaging for Staging Malignant Lymphomas
Inclusion Criteria:
- male or female patients
- age: 8 years and older
- histologically proven Hodgkin's disease or non-Hodgkin's lymphoma
- patients scheduled for a CT of the body for initial staging
- participant's parents (participant < 18 years) or the participant (participant >18
years) must willingly give written informed consent prior to the start of the study
- whole-body MRI has to be performed within 10 days before or after CT, and before
therapy has been started.
Exclusion Criteria:
- patients with a general contraindication for MRI (including cardiovascular
pacemakers, claustrophobia)
- patients who have had a previous malignancy
- patients who are pregnant or nursing
- patients in whom therapy has already started after CT and before MRI could be
performed
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Cross-Sectional
Outcome Measure:
The primary outcome will be the clinical stage according to WB-MRI findings and according to CT-findings. This clinical stage will be determined according to the Ann Arbor classification system.
Outcome Time Frame:
December 2010
Safety Issue:
No
Principal Investigator
Rutger A. J. Nievelstein, MD PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
UMC Utrecht
Authority:
Netherlands: Medical Ethics Review Committee (METC)
Study ID:
80-82310-98-08012
NCT ID:
NCT00685997
Start Date:
June 2008
Completion Date:
December 2010
Related Keywords:
- Malignant Lymphoma
- Hodgkin's Disease
- Non-Hodgkin's Lymphoma
- Malignant lymphoma
- Hodgkin's disease
- Non-Hodgkin's lymphoma
- Imaging
- Whole-Body MRI
- CT
- Radiation
- Hodgkin Disease
- Lymphoma
- Lymphoma, Non-Hodgkin
Name | Location |
|---|
